Trials / Unknown
UnknownNCT06042322
Retrospective Analysis of Pain After Nerve Block in Surgical Patients
Retrospective Analysis of Pain in Patients Who Receive a Nerve Block for Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 166 (estimated)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This is a retrospective study looking at patients who received a nerve block for surgery and assessing pain after the nerve block resolves, with or without an educational intervention, over two periods of time.
Detailed description
Regional anesthesia (RA) is a vital tool that can serve as the primary anesthetic or as part of a multimodal perioperative pain regimen. RA is strongly associated with decreased acute and persistent pain and opioid consumption postoperatively. However, some patients experience an acute worsening of pain into the severe range around the time of RA resolution, also known as "rebound pain" (RP). The incidence of RP has been reported as high as 40-50% after a single shot nerve block for patients undergoing ambulatory surgery. This retrospective study aims to look at patients who received a nerve block for surgery and assessing pain after the nerve block resolves in the presence and absence of certain interventions, such as a multidisciplinary educational intervention. The investigators will assess patients who received a primary total knee arthroplasty who received a single shot adductor canal nerve block, received pericapsular injection by the surgeon, and had a length of stay \> 16 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational intervention | Multidisciplinary educational intervention was performed by orthopedic, anesthesia, and nursing team. This included a discussion of the patient's pain plan and a patient visit. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2023-09-18
- Last updated
- 2024-01-10
Source: ClinicalTrials.gov record NCT06042322. Inclusion in this directory is not an endorsement.